Myocardial Infarction Prophylaxis
Myocardial infarction prophylaxis means reducing the chance of a first or recurrent heart attack. The balance of benefit and harm differs greatly between someone with established cardiovascular disease and someone without it.
Key takeaways
- Secondary prevention after a heart attack or established coronary disease is more intensive than prevention based on risk factors alone.
- Blood pressure, LDL cholesterol, diabetes, smoking and activity are addressed together rather than with one “heart-protection” medicine.
- Antiplatelet and beta-blocker treatment is not automatically appropriate for every person at elevated risk.
A prevention-medicine listing cannot calculate cardiovascular risk or define a regimen; disease history, bleeding risk, heart function and other conditions guide care.
How is prevention risk assessed?
Previous heart attack, coronary stent, angina or other arterial disease establishes high risk. Without known disease, age, blood pressure, lipids, diabetes, smoking, kidney function and family history inform a validated risk estimate and shared decisions.
What can medicine prevention include?
Metoprolol has selected roles after myocardial infarction, particularly when another cardiac indication is present, but benefit varies with heart function and time since the event. Lipid lowering, blood-pressure treatment and antiplatelet therapy are separately assessed within heart and blood pressure care.
When to seek urgent care
Prevention does not treat an active event. Call emergency services for chest pressure, sudden breathlessness, cold sweat, fainting, or pain spreading to an arm, jaw or back.